Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Titel:
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Auteur:
Rummel, Mathias Kaiser, Ulrich Balser, Christina Stauch, Martina Brugger, Wolfram Welslau, Manfred Niederle, Norbert Losem, Christoph Boeck, Hans-Peter Weidmann, Eckhart von Gruenhagen, Ulrich Mueller, Lothar Sandherr, Michael Hahn, Lars Vereshchagina, Julia Kauff, Frank Blau, Wolfgang Hinke, Axel Barth, Juergen